Paper23717166
Characterizing a full spectrum of physico-chemical properties of (20S)- and (20R)-ginsenoside Rg3 to be proposed as standard reference materials.
Kim IW and 5 others. J Ginseng Res, 2013. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Characterizing a full spectrum of physico-chemical properties of (20S)- and (20R)-ginsenoside Rg3 to be proposed as standard reference materials. Papers, record 23717166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23717166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterizing a full spectrum of physico-chemical properties of (20S)- and (20R)-ginsenoside Rg3 to be proposed as standard reference materials.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12882549 | Microbial transformation of ginsenoside Rb1 by Rhizopus stolonifer and Curvularia lunata. | Biotechnol Lett | 2003 | https://conductscience.org/library/papers/12882549 | PubMed |
| 2 | 16924497 | In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. | Cancer Chemother Pharmacol | 2007 | https://conductscience.org/library/papers/16924497 | PubMed |
| 3 | 23717084 | Trends in ginseng research in 2010. | J Ginseng Res | 2011 | https://conductscience.org/library/papers/23717084 | PubMed |
| 4 | 23717112 | Recent methodology in ginseng analysis. | J Ginseng Res | 2012 | https://conductscience.org/library/papers/23717112 | PubMed |
| 5 | 15015374 | [Studies on saponin constituents in roots of Panax quinquefolium]. | Zhongguo Zhong Yao Za Zhi | 2003 | https://conductscience.org/library/papers/15015374 | PubMed |
| 6 | 23717099 | Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng. | J Ginseng Res | 2012 | https://conductscience.org/library/papers/23717099 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38533264 | Korean red ginseng extract prevents bone loss in an oral model of glucocorticoid induced osteoporosis in mice. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38533264 | PubMed |
| 38476209 | Unveiling the experimental proof of the anticancer potential of ginsenoside Rg3 (Review). | Oncol Lett | 2024 | https://conductscience.org/library/papers/38476209 | PubMed |
| 38465219 | The pharmacological role of Ginsenoside Rg3 in liver diseases: A review on molecular mechanisms. | J Ginseng Res | 2024 | https://conductscience.org/library/papers/38465219 | PubMed |
| 38441023 | Ginsenoside Rg3: A Review of its Anticancer Mechanisms and Potential Therapeutic Applications. | Curr Top Med Chem | 2024 | https://conductscience.org/library/papers/38441023 | PubMed |
| 37764511 | Photoprotective Effects of Processed Ginseng Leaf Administration against UVB-Induced Skin Damage in Hairless Mice. | Molecules | 2023 | https://conductscience.org/library/papers/37764511 | PubMed |
| 37749560 | Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer. | Chin Med | 2023 | https://conductscience.org/library/papers/37749560 | PubMed |
| 35600861 | Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35600861 | PubMed |
| 32161549 | Relationship Between Ginsenoside Rg3 and Metabolic Syndrome. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32161549 | PubMed |
| 30344431 | A comparative study on immune-stimulatory and antioxidant activities of various types of ginseng extracts in murine and rodent models. | J Ginseng Res | 2018 | https://conductscience.org/library/papers/30344431 | PubMed |
| 28701863 | Inhibition of hypoxia-induced cyclooxygenase-2 by Korean Red Ginseng is dependent on peroxisome proliferator-activated receptor gamma. | J Ginseng Res | 2017 | https://conductscience.org/library/papers/28701863 | PubMed |
| 28287442 | A Strategy for Simultaneous Isolation of Less Polar Ginsenosides, Including a Pair of New 20-Methoxyl Isomers, from Flower Buds of Panax ginseng. | Molecules | 2017 | https://conductscience.org/library/papers/28287442 | PubMed |
| 26045689 | Anti-inflammatory activity of AP-SF, a ginsenoside-enriched fraction, from Korean ginseng. | J Ginseng Res | 2015 | https://conductscience.org/library/papers/26045689 | PubMed |
| 25535478 | Molecular mechanism of protopanaxadiol saponin fraction-mediated anti-inflammatory actions. | J Ginseng Res | 2015 | https://conductscience.org/library/papers/25535478 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23717166
GET https://conductscience.org/api/papers/v1/23717166/authors